Compound Evidence File
#EC-2026-0687
Tirzepatide(GLP-1 and GIP agonist)
Filed under Peptides. The bureau holds 1,474 laboratory returns for this compound from 148 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
148 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 1 Apr 2026 | 28 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 6 Mar 2026 | 20 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 23 Dec 2025 | 1 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 26 Nov 2025 | 7 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 11 Mar 2026 | 26 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 10.0 | 10.0 | 3 Apr 2026 | 27 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 7 Jan 2026 | 19 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 9.9 | 10.0 | 5 May 2026 | 2 Jul 2026 |
| Trusted PeptideCASE #VI-2026-0499 | A | 2 | 10.0 | 10.0 | 10.0 | 29 Dec 2025 | 29 Dec 2025 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 25 Dec 2025 | 27 Dec 2025 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Apr 2026 | 10 Jul 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 8 May 2026 | 4 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Apr 2026 | 22 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 9.9 | 9.9 | 9.9 | 14 Feb 2026 | 21 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 9.9 | 5 Feb 2026 | 15 Aug 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 18 May 2026 | 2 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 9.9 | 8 Jan 2026 | 27 May 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 18 May 2026 | 26 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 16 Mar 2026 | 10 Apr 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Apr 2026 | 14 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 24 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 18 Mar 2026 | 7 May 2026 |
| Risynth BioCASE #VI-2026-0672 | A | 4 | 9.5 | 8.4 | 10.0 | 1 Sep 2025 | 4 Sep 2025 |
| Aavant ResearchCASE #VI-2026-0831 | A | 6 | 9.3 | 8.1 | 10.0 | 24 Oct 2025 | 7 Jan 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 9.3 | 8.3 | 9.8 | 23 May 2026 | 23 May 2026 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | A | 2 | 9.0 | 8.0 | 10.0 | 25 Jul 2025 | 25 Jul 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | A | 15 | 8.8 | 6.5 | 10.0 | 17 Dec 2024 | 19 Jan 2026 |
| PeptiAtlasCASE #VI-2026-0739 | A | 4 | 8.8 | 6.3 | 10.0 | 17 Oct 2025 | 13 Dec 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | A | 3 | 8.8 | 8.2 | 9.2 | 23 Nov 2025 | 20 May 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | A | 9 | 8.6 | 7.4 | 9.8 | 3 Oct 2025 | 21 May 2026 |
| The Naughty NeedleCASE #VI-2026-0432 | A | 2 | 8.6 | 7.4 | 9.8 | 12 Dec 2025 | 12 Dec 2025 |
| Paradigm PeptideCASE #VI-2026-0759 | A | 10 | 8.5 | 6.8 | 10.0 | 5 Aug 2025 | 26 Jan 2026 |
| Atomik LabzCASE #VI-2026-0327 | A | 4 | 8.4 | 8.3 | 8.6 | 6 May 2025 | 7 May 2025 |
| M-PeptidesCASE #VI-2026-0442 | B | 10 | 8.4 | 6.0 | 9.8 | 20 Jun 2025 | 24 May 2026 |
| Simple PeptideCASE #VI-2026-0782 | B | 6 | 8.4 | 5.7 | 10.0 | 25 Apr 2025 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 8.3 | 7.9 | 8.9 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.2 | 7.6 | 9.0 | 21 May 2026 | 21 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | C | 6 | 8.2 | 4.2 | 9.8 | 11 Jun 2025 | 3 Oct 2025 |
| PeptiSlimCASE #VI-2026-0557 | E | 15 | 8.2 | 2.0 | 10.0 | 28 Aug 2025 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.1 | 6.5 | 9.1 | 21 May 2026 | 21 May 2026 |
| Nuscience PeptidesCASE #VI-2026-0554 | A | 6 | 8.0 | 6.8 | 10.0 | 7 May 2025 | 15 Jan 2026 |
| Laicuinuo LCNCASE #VI-2026-0223 | B | 7 | 8.0 | 5.2 | 10.0 | 30 Sep 2025 | 7 Jan 2026 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 8.0 | 8.0 | 8.0 | 25 Jul 2025 | 25 Jul 2025 |
| Skye PeptidesCASE #VI-2026-0451 | A | 11 | 7.9 | 6.2 | 8.8 | 17 Dec 2024 | 21 May 2026 |
| NextGen HealthCASE #VI-2026-0604 | A | 3 | 7.9 | 6.5 | 9.5 | 11 Jun 2025 | 4 Nov 2025 |
| Bfflist AMOCASE #VI-2026-0678 | C | 15 | 7.9 | 4.8 | 10.0 | 11 Jun 2025 | 21 May 2026 |
| Peptide-SCASE #VI-2026-0111 | D | 37 | 7.9 | 3.4 | 10.0 | 9 Jun 2025 | 24 May 2026 |
| Golden EagleCASE #VI-2026-0680 | B | 9 | 7.8 | 5.2 | 10.0 | 3 Aug 2025 | 21 May 2026 |
| HkRoidsCASE #VI-2026-0784 | C | 6 | 7.8 | 4.1 | 10.0 | 3 Jul 2025 | 26 Jan 2026 |
| SRY LabsCASE #VI-2026-0657 | D | 31 | 7.8 | 3.4 | 10.0 | 15 May 2025 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 7.7 | 7.3 | 8.5 | 25 May 2026 | 25 May 2026 |
| UtherCASE #VI-2026-0902 | C | 13 | 7.7 | 4.1 | 10.0 | 3 Jul 2025 | 6 Jan 2026 |
| Planet PeptideCASE #VI-2026-0092 | B | 18 | 7.6 | 5.5 | 10.0 | 17 Dec 2024 | 20 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | C | 24 | 7.6 | 4.4 | 10.0 | 9 Jun 2025 | 23 May 2026 |
| HealthTide BiotechCASE #VI-2026-0955 | C | 6 | 7.6 | 4.4 | 10.0 | 5 Aug 2025 | 23 May 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.6 | 7.6 | 7.6 | 13 Jun 2025 | 13 Jun 2025 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | A | 5 | 7.5 | 6.3 | 9.8 | 11 Jun 2025 | 21 May 2026 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | A | 4 | 7.4 | 6.3 | 8.0 | 25 Jul 2025 | 17 Oct 2025 |
| Amino LairCASE #VI-2026-0413 | B | 6 | 7.4 | 5.7 | 9.7 | 11 Aug 2025 | 7 Jan 2026 |
| Peptronix Bio PTBCASE #VI-2026-0979 | B | 5 | 7.4 | 5.8 | 9.2 | 25 Jul 2025 | 21 May 2026 |
| Eternal PeptidesCASE #VI-2026-0842 | B | 4 | 7.4 | 5.8 | 8.5 | 7 May 2025 | 21 May 2025 |
| Anlv BiotechnologyCASE #VI-2026-0110 | C | 7 | 7.4 | 4.9 | 10.0 | 31 Aug 2025 | 25 May 2026 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | C | 4 | 7.4 | 4.8 | 9.7 | 3 Jun 2025 | 24 May 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | E | 15 | 7.4 | 2.0 | 10.0 | 17 Oct 2025 | 23 May 2026 |
| Reta-PeptideCASE #VI-2026-0756 | D | 23 | 7.3 | 3.5 | 10.0 | 20 Jun 2025 | 24 May 2026 |
| Henan Sahe PeptideCASE #VI-2026-0894 | D | 7 | 7.3 | 3.4 | 10.0 | 3 Oct 2025 | 26 Jan 2026 |
| NexaphCASE #VI-2026-0944 | E | 42 | 7.3 | 3.0 | 10.0 | 2 Jul 2025 | 24 May 2026 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 7.3 | 7.3 | 7.3 | 20 Jun 2025 | 20 Jun 2025 |
| Verified PeptidesCASE #VI-2026-0407 | A | 4 | 7.2 | 7.0 | 7.5 | 13 Feb 2025 | 19 Feb 2025 |
| Peptide HavenCASE #VI-2026-0898 | B | 2 | 7.2 | 5.9 | 8.4 | 2 Dec 2025 | 2 Dec 2025 |
| Huayi BiotechnologyCASE #VI-2026-0243 | C | 8 | 7.2 | 5.0 | 9.9 | 1 Sep 2025 | 24 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | E | 99 | 7.2 | 0.0 | 10.0 | 11 Jun 2025 | 25 May 2026 |
| Coastal PeptidesCASE #VI-2026-0958 | A | 5 | 7.1 | 6.5 | 7.9 | 27 Feb 2025 | 20 Mar 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | A | 2 | 7.1 | 6.5 | 7.6 | 21 May 2025 | 21 May 2025 |
| LSPLCASE #VI-2026-0523 | C | 14 | 7.1 | 4.5 | 10.0 | 11 Jun 2025 | 21 May 2026 |
| LiliPeptideCASE #VI-2026-0695 | E | 25 | 7.1 | 0.0 | 10.0 | 1 Sep 2025 | 24 May 2026 |
| PurePeptidesCASE #VI-2026-0234 | B | 6 | 7.0 | 6.6 | 7.8 | 27 Feb 2025 | 4 Sep 2025 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | D | 21 | 7.0 | 3.2 | 10.0 | 6 Oct 2025 | 23 May 2026 |
| Xingruida XDRCASE #VI-2026-0898 | D | 18 | 7.0 | 3.9 | 10.0 | 4 Sep 2025 | 21 May 2026 |
| ZLZ PeptideCASE #VI-2026-0524 | E | 70 | 7.0 | 0.0 | 10.0 | 20 Jun 2025 | 24 May 2026 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | E | 27 | 7.0 | 0.0 | 10.0 | 21 Aug 2025 | 24 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | E | 16 | 7.0 | 2.0 | 10.0 | 25 Nov 2025 | 24 May 2026 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 7.0 | 7.0 | 7.0 | 24 May 2026 | 24 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | B | 10 | 6.9 | 5.4 | 10.0 | 14 Nov 2025 | 24 May 2026 |
| Pure RawzCASE #VI-2026-0767 | B | 4 | 6.9 | 6.3 | 7.7 | 7 May 2025 | 21 May 2025 |
| Eros PeptidesCASE #VI-2026-0918 | B | 3 | 6.9 | 5.8 | 8.6 | 8 Jul 2025 | 3 Oct 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | B | 3 | 6.9 | 5.8 | 8.0 | 2 Apr 2025 | 2 Apr 2025 |
| BeiBangAnCASE #VI-2026-0899 | D | 15 | 6.9 | 4.0 | 10.0 | 5 Dec 2025 | 23 May 2026 |
| Top PeptideCASE #VI-2026-0721 | D | 15 | 6.9 | 4.0 | 9.5 | 5 Aug 2025 | 24 May 2026 |
| OupeptideCASE #VI-2026-0435 | E | 56 | 6.9 | 0.0 | 10.0 | 3 Jun 2025 | 24 May 2026 |
| Qing Li PeptideCASE #VI-2026-0469 | E | 36 | 6.9 | 2.9 | 10.0 | 3 Jul 2025 | 21 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | E | 20 | 6.9 | 2.6 | 10.0 | 20 Jun 2025 | 25 May 2026 |
| LN PeptidesCASE #VI-2026-0781 | C | 13 | 6.8 | 4.8 | 10.0 | 3 Oct 2025 | 21 May 2026 |
| Paramount PeptidesCASE #VI-2026-0550 | D | 11 | 6.8 | 3.6 | 8.9 | 14 Jan 2025 | 17 May 2026 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | E | 24 | 6.8 | 1.6 | 9.8 | 3 Jun 2025 | 24 May 2026 |
| HXNetCASE #VI-2026-0061 | E | 27 | 6.7 | 2.3 | 10.0 | 9 Jun 2025 | 24 May 2026 |
| Alpha-GenCASE #VI-2026-0905 | B | 5 | 6.6 | 5.5 | 7.0 | 24 Apr 2025 | 21 May 2025 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | E | 31 | 6.6 | 2.0 | 10.0 | 25 Jul 2025 | 24 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | E | 20 | 6.6 | 1.4 | 9.7 | 23 Oct 2025 | 24 May 2026 |
| ZhuoYan labCASE #VI-2026-0902 | E | 18 | 6.6 | 2.5 | 9.7 | 2 Jul 2025 | 29 Jan 2026 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | E | 15 | 6.6 | 0.0 | 10.0 | 8 Jul 2025 | 24 May 2026 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | B | 5 | 6.5 | 5.5 | 9.5 | 9 Jun 2025 | 19 Jan 2026 |
| Bio PepzCASE #VI-2026-0436 | B | 4 | 6.5 | 5.3 | 7.6 | 5 Nov 2025 | 17 Nov 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | E | 17 | 6.5 | 0.0 | 9.7 | 11 Dec 2025 | 23 May 2026 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | E | 8 | 6.5 | 0.0 | 8.6 | 20 Jun 2025 | 29 Dec 2025 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | E | 4 | 6.5 | 2.0 | 10.0 | 29 Jun 2025 | 5 Nov 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 6.5 | 6.5 | 6.5 | 25 May 2026 | 25 May 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | B | 5 | 6.4 | 5.4 | 7.7 | 6 Aug 2025 | 9 Oct 2025 |
| Zztai PeptideCASE #VI-2026-0192 | C | 19 | 6.4 | 4.1 | 9.8 | 9 Jun 2025 | 9 Jan 2026 |
| Royal PeptidesCASE #VI-2026-0264 | C | 10 | 6.4 | 4.2 | 9.5 | 16 Mar 2025 | 24 May 2026 |
| Loti LabsCASE #VI-2026-0171 | C | 10 | 6.4 | 4.2 | 8.0 | 16 Mar 2025 | 7 May 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | C | 8 | 6.4 | 4.4 | 7.7 | 11 Jun 2025 | 5 Dec 2025 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | C | 5 | 6.4 | 4.1 | 7.7 | 29 Jun 2025 | 18 Sep 2025 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | D | 16 | 6.4 | 3.5 | 8.0 | 11 Jun 2025 | 24 May 2026 |
| Alimo PeptideCASE #VI-2026-0524 | D | 4 | 6.4 | 3.8 | 10.0 | 11 Jun 2025 | 11 Aug 2025 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 14 | 6.3 | 4.1 | 9.9 | 25 Jul 2025 | 21 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | C | 9 | 6.3 | 4.3 | 8.0 | 11 Jun 2025 | 21 May 2026 |
| Peptide SciencesCASE #VI-2026-0867 | D | 15 | 6.3 | 3.8 | 8.0 | 28 Mar 2025 | 24 May 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | D | 15 | 6.3 | 3.4 | 8.0 | 30 Sep 2025 | 23 May 2026 |
| Quenna PMQCASE #VI-2026-0415 | D | 8 | 6.3 | 3.7 | 9.0 | 16 Jul 2025 | 21 May 2026 |
| NextechLabsCASE #VI-2026-0285 | C | 6 | 6.2 | 5.0 | 7.3 | 14 Jan 2025 | 20 Mar 2025 |
| Evolve BioPepCASE #VI-2026-0755 | C | 6 | 6.2 | 4.9 | 8.0 | 2 Jul 2025 | 19 Jan 2026 |
| Yabang PeptideCASE #VI-2026-0148 | C | 6 | 6.2 | 4.4 | 7.7 | 14 Oct 2025 | 14 Oct 2025 |
| Heman Peptide HMCASE #VI-2026-0089 | D | 6 | 6.2 | 3.3 | 9.7 | 7 Oct 2025 | 25 May 2026 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | E | 4 | 6.2 | 0.0 | 9.5 | 2 Jul 2025 | 30 Dec 2025 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | C | 7 | 5.9 | 4.9 | 7.8 | 25 Nov 2025 | 24 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 5.9 | 5.9 | 5.9 | 11 Jun 2025 | 11 Jun 2025 |
| Peptide CraftersCASE #VI-2026-0994 | C | 5 | 5.8 | 4.2 | 7.8 | 17 Dec 2024 | 20 Mar 2025 |
| Amino AsylumCASE #VI-2026-0828 | C | 2 | 5.8 | 4.7 | 7.0 | 14 Feb 2025 | 19 Feb 2025 |
| ZZQ PeptidesCASE #VI-2026-0550 | E | 11 | 5.8 | 1.3 | 7.8 | 3 Jul 2025 | 24 May 2026 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 23 | 5.6 | 0.0 | 10.0 | 3 Jun 2025 | 19 May 2026 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 5.6 | 5.6 | 5.6 | 25 May 2026 | 25 May 2026 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | E | 7 | 5.5 | 0.0 | 7.9 | 8 Jul 2025 | 26 Jan 2026 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | E | 6 | 5.5 | 2.3 | 7.8 | 18 Sep 2025 | 24 May 2026 |
| TydesCASE #VI-2026-0493 | C | 10 | 5.4 | 4.6 | 6.2 | 17 Dec 2024 | 30 Apr 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | E | 5 | 5.3 | 2.2 | 8.3 | 5 Aug 2025 | 23 May 2026 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | E | 8 | 5.2 | 0.0 | 9.2 | 11 Jun 2025 | 24 May 2026 |
| Elite Research USACASE #VI-2026-0267 | D | 4 | 5.0 | 4.0 | 6.6 | 20 Jun 2025 | 5 Aug 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 4.9 | 4.9 | 4.9 | 17 Jul 2025 | 17 Jul 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | D | 5 | 4.8 | 4.2 | 6.0 | 28 Mar 2025 | 24 Jul 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 4.7 | 4.7 | 4.7 | 25 May 2026 | 25 May 2026 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | E | 5 | 4.3 | 1.9 | 5.9 | 23 Oct 2025 | 29 Dec 2025 |
| Amino AmigosCASE #VI-2026-0061 | E | 8 | 4.0 | 3.7 | 4.6 | 14 Jan 2025 | 16 Jul 2025 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 4.0 | 4.0 | 4.0 | 11 Jun 2025 | 11 Jun 2025 |
| Peptide GurusCASE #VI-2026-0854 | E | 6 | 3.3 | 2.2 | 4.4 | 16 Mar 2025 | 25 Mar 2025 |
| DeuschemCASE #VI-2026-0004 | E | 4 | 1.0 | 1.0 | 1.0 | 13 Jun 2025 | 5 Aug 2025 |
Open any subject to view the batch-level evidence for Tirzepatide(GLP-1 and GIP agonist) alone.